PharmEasy CEO hopes to return to market with an IPO if robust performance sustains on December 15, 2023 at 9:33 am

The company is awaiting Competition Commission of India (CCI) approval for the rights issue.

Leave a comment

Your email address will not be published. Required fields are marked *